Error: Could not add to watchlist. X
+ Watchlist

AnGes MG Inc

AMGXF:US
OTC US
Price not available for AMGXF:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (JPY) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
78.631
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
AnGes MG, Inc. develops gene-therapy drugs that use Hepatocyte Growth Factor (HGF) for myocardial infarction and arteriosclerosis patients. The Company also develops nucleic acid drug (decoy oligo) for patients with asthma, allergy, and rheumatism. AnGes MG develops vectors (a carrier used to introduce a foreign gene into a host cell) which help study and analyze genetic functions.
Address
7-7-15 Saitoasagi
Ibaraki, 567-0085
Japan
Phone
81-03-5730-2753
  • Ei Yamada
    President/CEO
  • Seiji Hirasaki
    Executive Officer
Show More